UNC School of Medicine researchers have led an international clinical trial of patients with generalized myasthenia gravis, finding the therapy is safe and effective across all subtypes.This article was originally published on MedicalXpress.com
A major international study involving 23,000 people has found concerning evidence about the impact of a range of common, everyday medications on the treatment outcomes for patients with breast cancer.This article was originally published on […]
A University of Manchester study reveals a drug approved for use in other conditions could be repurposed as a preventive breast cancer treatment in women before menopause.This article was originally published on MedicalXpress.com
A pioneering patient-reported outcome tool, developed by health care company Observia with the support of Kingston University, has shown significant promise in predicting the risk of a patient with chronic conditions not following their treatment […]
A commonly prescribed antibiotic could help reduce the risk of some young people developing schizophrenia, new research published in the American Journal of Psychiatry suggests.This article was originally published on MedicalXpress.com
Certain medicines can cause the environmental toxin PFAS to be eliminated from the body faster, according to a study from the University of Gothenburg. The findings highlight one more medicine as effective, but whether it […]
Since the height of the opioid epidemic, doctors have been prescribing fewer of these medications. A new study from UC San Francisco shows that this trend extends to nursing home residents who may need opioids […]
Patients with severe mental illnesses, such as schizophrenia and bipolar disorder, often require long-term use of antipsychotic medications. Some of these drugs, however, can pose potential risks, such as elevated prolactin levels and compromised immune […]
In the absence of much federal action, states have enacted dozens of laws this year to lower prescription drug costs for their residents—and many more are considering following suit.This article was originally published on MedicalXpress.com
A new observational study compared the risk for severe gastrointestinal adverse events across dulaglutide, semaglutide, and tirzepatide in patients with type 2 diabetes (T2D). The study found that the medications have similar gastrointestinal safety profiles […]
© 2025 SimplyWell.ca